Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges
Study context
- Population
- Patients with T2D
- Comparison
- Continuous subcutaneous insulin infusion (CSII) in T2D
Main finding
As reported in the abstract
- CSII is rarely recommended by healthcare professionals and is underutilized in T2D management
Original publication
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges. Diabetes Obes Metab. Published 13 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →